Company intelligence / Profile preview
Nowarta Biopharma Inc.
Huntington Beach, California, United Statesnowarta.com ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Phase 2
01
Overview
Successfully completed Phase I/II randomized double-blind clinical study for Nowarta110 with 64.3% efficacy versus 7.7% for placebo in treating plantar warts by week 6, with zero serious adverse events reported[2][3][9]
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small molecule drugBotanical drug
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Nowarta Biopharma Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nowarta Biopharma Inc..